Introduction

CJC-1295 with DAC is a GHRH analog peptide modified with DAC (Drug Affinity Complex) to extend its half-life. This modification allows long-term growth hormone stimulation in laboratory studies, making it a highly valuable peptide for research on metabolism and tissue development.

1. Molecular Structure

• GHRH analog peptide
• DAC modification for extended activity
• Stable in lyophilized form

This structure supports studies that require sustained hormone signaling.

2. Mechanism and Research Applications

CJC-1295 with DAC is studied for:

• Long-lasting growth hormone release
• Metabolic regulation and tissue repair studies
• Combination peptide experiments with Ipamorelin or GHRP-6

Its extended half-life reduces dosing frequency in experimental protocols.

3. Storage and Handling

• Keep lyophilized until use
• Store at 2–8°C
• Avoid moisture and repeated freeze-thaw cycles
• Use sterile reconstitution methods

4. Comparison With Other Peptides

5. Future Research Directions

• Combination therapy with GHRPs for enhanced GH pulsatility
• Optimization of long-term metabolic studies
• Stability improvements in formulation

Conclusion

CJC-1295 with DAC is a highly stable, long-acting GHRH analog peptide for growth hormone research. Proper handling, storage, and experimental design ensure reproducible and reliable outcomes.

FAQ

Q1: What is CJC-1295 with DAC peptide?
A: A GHRH analog peptide with DAC modification for extended half-life.

Q2: How does it work?
A: Stimulates long-lasting growth hormone release.

Q3: How should it be stored?
A: Lyophilized, refrigerated, and kept dry.

Q4: How does it compare with Ipamorelin?
A: CJC-1295 with DAC is long-acting; Ipamorelin is short-acting.

Q5: How to handle CJC-1295 with DAC in the lab?
A: Use sterile conditions, avoid repeated freeze-thaw, and store properly.